FAIRFAX, Va.--(BUSINESS WIRE)--Virginia Cancer Specialists (VCS) announced that Hernan Vargas, MD, has joined the practice. VCS, a practice in The US Oncology Network, is a premier cancer care and research center in Northern Virginia with more than 40 years of service to patients.
Dr. Vargas joins VCS with more than 20 years of experience in the care of women with breast cancer and benign conditions of the breast. Previously, he served as Associate Professor of Surgery at UCLA as well as the Director of the Breast Programs at Harbor-UCLA in Los Angeles and at Inova Fair Oaks Hospital in Fairfax, Virginia. He has contributed to the development of new surgical techniques in breast cancer care, being the author of more than 100 scientific publications. Most importantly, Dr. Vargas’ goal is to provide high-quality, patient-centered care within a multidisciplinary group of like-minded individuals.
“Breast cancer patients meet us during one of the most vulnerable times in their lives,” said Dr. Vargas. “For those of us who see this as a calling and not just a job, we have the privilege of helping patients, guiding them at this time when they need it most.”
In addition to his clinical work, Dr. Vargas has lectured nationally and internationally. He is the recipient of several awards for leadership and teaching excellence and has been recognized as a “Top Doctor” in breast surgery by Washingtonian Magazine, LA Magazine and Castle-Connolly’s America’s Top Doctors for Cancer.
“We are proud to welcome Dr. Vargas to our exceptional breast care team,” said Linda Anderson, executive director, VCS. “His expertise and patient-centered focus will be extraordinary additions to our new line of breast surgery services offered to patients as part of our 360-degree approach to patient care.”
Dr. Vargas is a board-certified surgeon who attended the Alberto Hurtado School of Medicine in Lima, Peru. He completed his residency at UCLA Medical Center in Los Angeles as well as his fellowship at The National Cancer Institute of Health in Bethesda, Maryland. He is currently treating patients at the VCS Fair Oaks location. Call 703-208-9350 for an appointment.
About Virginia Cancer Specialists
For more than 40 years, Virginia Cancer Specialists (VCS) has contributed to the campaign against cancer and diseases of the blood. VCS has nine locations throughout Northern Virginia staffed by highly-skilled physicians, each delivering exceptional care. The practice has built a world-class treatment team of cancer specialists, as well as acquiring the very latest treatment technology to help achieve the best outcomes for patients. VCS unites medical and radiation oncologists, breast and musculoskeletal surgeons, hematologists, palliative care physicians, oncology nurse navigators, oncology infusion nurses, radiation therapists, genetic counselors, oncology pharmacists and laboratory technicians. All working together, this team designs the optimal multidisciplinary treatment program, efficiently shares knowledge, executes the treatment plan, and provides a patient-centered, consumer-friendly approach to cancer care. Patients receive the full spectrum of high-quality care necessary to treat their disease from a care team united in their effort to provide each patient with the specific personalized care they need to battle cancer. The physicians at VCS have published more than 100 abstracts and papers over the last few years and have been invited to present at national meetings. To learn more about Virginia Cancer Specialists, please visit www.VirginiaCancerSpecialists.com.
Virginia Cancer Specialists is an affiliate of The US Oncology Network (The Network). This collaboration unites VCS with more than 1,400 independent physicians dedicated to delivering value-based, integrated care for patients — close to home. Through The Network, these independent doctors come together to form a community of shared expertise and resources dedicated to advancing local cancer care and to delivering better patient outcomes. The US Oncology Network is supported by McKesson Specialty Health, whose coordinated resources and infrastructure allow doctors in The Network to focus on the health of their patients, while McKesson focuses on the health of their practices. VCS also participates in clinical trials through US Oncology Research, which has played a role in more than 70 FDA-approved cancer therapies, approximately one-third of all cancer therapies approved by the FDA to date. For more information, visit www.usoncology.com.